Join A Recurrent UTI Prevention Study
If you have a history of recurrent urinary tract infections (UTIs) and would like to contribute to clinical research, you may be eligible to enroll in Bonafide Health’s urinary health study.
Recurrent UTIs are one of the most common infections, with an estimated 60% of women experiencing at least one during their lifetime. While advances continue to be made in understanding and treating urinary health conditions – and the number of products addressing UTIs continues to grow – many women live with frequent recurrence of symptoms.
While the gold standard UTI treatment – a course of antibiotics – can mitigate UTI symptoms, up to half of all patients will have a recurrence of symptoms within 6 months.
Researchers at Bonafide Health are looking for women with recurrent UTIs who are interested in joining a clinical study examining the efficacy of FLUSH, a dietary drink mix. Participation in the study can be completed from home.
What is FLUSH?
Who can participate?
You may be eligible to participate if you:
- Are a woman aged 18-65.
- Currently reside in the United States.
- Experience recurrent UTIs* and are otherwise healthy.
- Are not currently pregnant and do not plan to become pregnant in the next 6 months.
- Are willing and able to agree to the requirements of the study.
*Recurrent UTI is defined as experiencing 2 or more UTIs in the last 6 months OR 3 or more UTIs in the last 12 months.
Will participation impact my usual UTI care or maintenance approach?
This clinical trial is a randomized, 3-arm trial. If enrolled, you will be randomized into 1 of 3 groups. Two of these groups will receive the FLUSH supplement, and one group will not receive any study product. You will be assigned to one of the following groups:
- Group 1: Consume the FLUSH dietary drink mix once daily.
- Group 2: Consume the FLUSH dietary drink mix once every three days and after sex, if applicable.
- Group 3: Continue your current treatment plan with no additional intervention.
Participants in the trial may continue using any supplements they usually take for UTI management or general health, but should not introduce any new supplements for the first time during the trial.
If a participant experiences a UTI during the trial, they should take their typical approach to seeking UTI care and/or treatment, including taking antibiotics, if required. Those assigned to group 1 or 2 should also continue to consume the FLUSH dietary mix.
What does study participation require?
After completing the pre-screener form, those who may be eligible for the trial will be invited to complete an electronic informed consent form and a medical history questionnaire. Following this, the participant will be invited to attend a virtual visit with a research team member to complete the screening process. The virtual visit will take place via a Microsoft Teams call, or a phone call.
Those who are enrolled in the trial may complete their participation at home, or another location of their choosing. No in-person visits are required. For those in the product arms of the study, the FLUSH product will be shipped directly to the address they provide. Participants in all groups may earn up to $500 for completion of this study.
During the trial, you will be asked to track and report on your urinary health over the course of 6 months, which will include:
- Completing an online questionnaire on a daily, biweekly, and monthly basis (daily time commitment about 5 minutes).
- Attending 3 virtual visits with a research team member via a Microsoft Teams call, or a phone call. These visits will occur in month 2, 4 and 6.
You won’t have to collect any samples!
Are there any benefits in participating?
Participants in the product arms of the study will receive the FLUSH product free of charge, to be taken on the basis described for their group.
Participants in all groups may earn up to $500 for completion of this study!
Interested in participating? Click here to fill out the pre-screener.
How Can I Join The Study?
If you’d like to enroll in the study, you must first meet several criteria. You can fill out the pre-screener form so the research team can assess initial eligibility. Please note that you must currently have an active UTI or have had one in the past 7 days to enroll. You will not be required to provide proof of a medical diagnosis or UTI test result.
If you have not experienced an active UTI in the past 7 days, you can still fill out the pre-screener form. The form will provide steps for you to complete in the event that you experience another UTI episode and wish to enroll at that time.
If you fill out the pre-screener form and meet initial requirements for the study, you will be sent further information about participation requirements by email. You will be contacted to arrange a screening visit, during which a member of the Bonafide Health clinical team will affirm your eligibility and enroll you into the study.
Completing the pre-screening questionnaire does not represent a commitment to enrolling in the study, and you will have the opportunity to withdraw interest at any time. Participation is completely voluntary.
You can earn up to $500 from participating!
If you have questions about this clinical study, you may contact the Bonafide Health clinical research team at [email protected]